Semaglutide vs Sermorelin

Reviewed by Gabriel Brocklesby · Last updated

Semaglutide is associated with weight management pathways while sermorelin appears in hormone optimisation and longevity contexts. Use clinic profiles to compare service scope and clinician oversight.

Semaglutide and sermorelin typically appear in different clinical contexts — metabolic health versus hormone optimisation. If a clinic offers both, ask how each fits into its assessment model and monitoring plan. This page is for comparing provider approaches, not clinical suitability.

Semaglutide

A GLP-1 receptor agonist used in weight management and metabolic health programmes.

Potential benefits

  • Widely referenced in weight-management clinics.
  • Often paired with lifestyle and monitoring support.

Considerations

  • Requires licensed prescriber oversight.
  • Suitability depends on individual assessment.
Best for: Comparing weight-management providers and their clinical governance.

Sermorelin

A growth hormone–releasing hormone analogue listed in longevity and hormone optimisation clinics.

Potential benefits

  • Commonly referenced in longevity protocols.
  • Often paired with other secretagogues.

Considerations

  • Evidence quality varies by clinic and jurisdiction.
  • Requires structured monitoring.
Best for: Comparing hormone optimisation clinics and consultation depth.
CategorySemaglutideSermorelin
Directory contextInformational clinic and treatment comparison context.Informational clinic and treatment comparison context.
Common goalsCompare how clinics frame suitability, monitoring, and expected use cases.Compare how clinics frame suitability, monitoring, and expected use cases.
Guidance noteInformational listing only; suitability requires clinician review.Informational listing only; suitability requires clinician review.

Next step

Compare clinics offering these treatments

Use city pages and peptide-specific pages to move from general research into actual provider shortlists. That usually gives a better buying picture than comparing drug names alone.

Related clinics

FeaturedVerified

Menon Health

London, United Kingdom

Menon Health is a Mayfair-based peptide therapy clinic founded by Dr Mukil Menon, a GMC-registered physician and one of the first doctors to prescribe medical peptide therapy in the UK. Before establishing Menon Health, Dr Menon served as UK medical director at Koniver Wellness, launching the clinic at Soho House London. He continues to practise within the NHS alongside his private consultations, ensuring his protocols stay grounded in current medical standards. The clinic offers doctor-led, prescription-based peptide therapy alongside regenerative cell complex treatments, bloods and diagnostics, and IV therapy. All formulations are sourced from GMP-certified, EMA-regulated pharmacies and dispensed as pre-filled pens, vials, or multi-peptide syringes — Menon Health's approach to combining multiple peptides in a single dose is designed to improve precision and patient adherence. Based at 64 North Row in Mayfair, London, Menon Health serves patients across the UK, Europe, Canada, and the United States, with consultations available in person or remotely.

In personRemoteFrom £195Virtual consultations
View ProfileSend EnquiryCompare

Conclusion

These are often offered by different types of clinics. Choose based on your goal and the provider’s clinical governance rather than the peptide label.

Related peptide pages

US city pages

For clinics

Are you a clinic?

Get featured on this page and reach patients actively looking for peptide therapy, GLP-1 treatments, recovery support, and longevity care.